Onderneming Immune Pharmaceuticals, Inc. OTC Markets
Aandelen
IMNPQ
US45254C2008
Farmaceutische producten
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- USD | -.--% | -.--% | -23,08% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 37 | 12-04-21 | |
Devin J. Shaw
DFI | Director of Finance/CFO | 37 | 13-04-21 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 11-12-17 |
Tony Fiorino
BRD | Director/Board Member | 56 | 15-08-17 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
John P. Clark
AUD | Comptroller/Controller/Auditor | 52 | 20-11-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | - |
Tony Fiorino
BRD | Director/Board Member | 56 | 15-08-17 |
John A. Neczesny
BRD | Director/Board Member | 60 | 02-02-16 |
Daniel Kazado
BRD | Director/Board Member | 59 | 10-10-13 |
Jeff Paley
BRD | Director/Board Member | 55 | 23-02-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 3 713 | 0 | 0 | 100,00 % |
Aandeel B | 1 | 172 878 093 | 172 878 093 ( 100,00 %) | 0 |
Bedrijfsgegevens
Immune Pharmaceuticals, Inc.
1 Bridge Plaza North Suite 270
07024, Englewood Cliffs
+201-464-2677
http://www.immunepharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,47% | 664 mld. | |
+25,70% | 567 mld. | |
-6,33% | 354 mld. | |
+19,35% | 330 mld. | |
+4,23% | 286 mld. | |
+13,42% | 234 mld. | |
+4,71% | 199 mld. | |
-10,10% | 196 mld. | |
-4,04% | 148 mld. |
- Beurs
- Aandelen
- Koers FZRQ
- Koers IMNPQ
- Onderneming Immune Pharmaceuticals, Inc.